| __timestamp | Amicus Therapeutics, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 79529000 |
| Thursday, January 1, 2015 | 47269000 | 91224000 |
| Friday, January 1, 2016 | 71151000 | 102413000 |
| Sunday, January 1, 2017 | 88671000 | 146987000 |
| Monday, January 1, 2018 | 127200000 | 213695000 |
| Tuesday, January 1, 2019 | 169861000 | 342000000 |
| Wednesday, January 1, 2020 | 156407000 | 661000000 |
| Friday, January 1, 2021 | 192710000 | 1283000000 |
| Saturday, January 1, 2022 | 213041000 | 2676000000 |
| Sunday, January 1, 2023 | 275270000 | 3297000000 |
| Monday, January 1, 2024 | 3790000000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Genmab A/S and Amicus Therapeutics, Inc. have shown contrasting approaches. From 2014 to 2023, Genmab A/S's SG&A expenses surged by over 4,000%, peaking at approximately $3.3 billion in 2023. In contrast, Amicus Therapeutics, Inc. exhibited a more moderate increase of around 1,200%, reaching $275 million in the same year. This stark difference highlights Genmab's aggressive expansion strategy, while Amicus appears to maintain a more conservative approach. Investors and industry analysts often scrutinize such trends to gauge a company's operational efficiency and strategic direction. As the biotech sector continues to evolve, understanding these financial dynamics becomes essential for stakeholders aiming to make informed decisions.
Eli Lilly and Company vs Genmab A/S: SG&A Expense Trends
Vertex Pharmaceuticals Incorporated vs Genmab A/S: SG&A Expense Trends
Comparing SG&A Expenses: BeiGene, Ltd. vs Amicus Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Genmab A/S and Blueprint Medicines Corporation
Genmab A/S vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Genmab A/S vs Travere Therapeutics, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Alkermes plc and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. or Vericel Corporation: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs Mesoblast Limited
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Travere Therapeutics, Inc.